Ventilator-associated pneumonia during weaning from mechanical ventilation: Role of fluid management

Chest

Volumn 146, Issue 1, 2014, Pages 58-65

  Dessap, Armand Mekontso ^a,c,d   Katsahian, Sandrine ^b   Roche Campo, Ferran ^a,e,f   Varet, Hugo ^b   Kouatchet, Achille ^g   Tomicic, Vinko ^h,i   Beduneau, Gaetan ^j   Sonneville, Romain ^k   Jaber, Samir ^l   Darmon, Michael ^o   Castanares Zapatero, Diego ^m   Brochard, Laurent ⁿ   Brun Buisson, Christian ^a,c,d  

^a HENRI MONDOR HOSPITAL   (France)

^b Unité de Recherche Clinique   (France)

^c FACULTÉ DE MÉDECINE   (France)

^d INSERM   (France)

^e HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^f ANGERS UNIVERSITY HOSPITAL   (France)

^g UNIVERSIDAD DEL DESARROLLO   (Chile)

^h ROUEN UNIVERSITY HOSPITAL   (France)

ⁱ ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^j HÔPITAL SAINT ELOI   (France)

^k SAINT LOUIS HOSPITAL   (France)

^l CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^m ST MICHAEL'S HOSPITAL   (Canada)

ⁿ UNIVERSITY OF TORONTO   (Canada)

^o University of Toronto ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; COMPLICATION; CONTROLLED STUDY; DATA ANALYSIS; EUROPE; FEMALE; FINE AND GRAY MODEL; FLUID THERAPY; HAZARD RATIO; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROBABILITY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STATISTICAL MODEL; VENTILATOR ASSOCIATED COMPLICATION; VENTILATOR ASSOCIATED PNEUMONIA; WESTERN HEMISPHERE;

AGED; DIURETICS; EUROPE; FEMALE; FLUID THERAPY; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; RESPIRATION, ARTIFICIAL; SOUTH AMERICA; TREATMENT OUTCOME; VENTILATOR WEANING;

EID: 84903822113     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-2564     Document Type: Article

References (30)

1. Melsen WG, Rovers MM, Koeman M, Bonten MJ. Estimat ing the attributable mortality of ventilator-associated pneu monia from randomized prevention studies. Crit Care Med. 2011; 39 (12): 2736-2742.
2. Bekaert M, Timsit JF, Vansteelandt S, et al; Outcomerea Study Group. Attributable mortality of ventilatorassociated pneumonia: a reappraisal using causal analysis. Am J Respir Crit Care Med. 2011; 184 (10): 1133-1139.
3. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002; 165 (7): 867-903.
4. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med. 1998; 129 (6): 433-440.
5. Magill SS, Klompas M, Balk R, et al. Developing a new, national approach to surveillance for ventilator-associated events: executive summary. Chest. 2013; 144 (5): 1448-1452.
6. Delclaux C, Roupie E, Blot F, Brochard L, Lemaire F, Brun-Buisson C. Lower respiratory tract colonization and infection during severe acute respiratory distress syndrome: incidence and diagnosis. Am J Respir Crit Care Med. 1997; 156 (4 pt 1): 1092-1098.
7. Meduri GU, Reddy RC, Stanley T, El-Zeky F. Pneumonia in acute respiratory distress syndrome. A prospective evaluation of bilateral bronchoscopic sampling. Am J Respir Crit Care Med. 1998; 158 (3): 870-875.
8. Chastre J, Trouillet JL, Vuagnat A, et al. Nosocomial pneumonia in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 1998; 157 (4 pt 1): 1165-1172.
9. Fleischmann KE, Goldman L, Young B, Lee TH. Association between cardiac and noncardiac complications in patients undergoing noncardiac surgery: outcomes and eff ects on length of stay. Am J Med. 2003; 115 (7): 515-520.
10. Richardson JD, Woods D, Johanson WG Jr, Trinkle JK. Lung bacterial clearance following pulmonary contusion. Surgery. 1979; 86 (5): 730-735.
11. Mekontso Dessap A, Roche-Campo F, Kouatchet A, et al. Natriuretic peptide-driven fl uid management during ventilator weaning: a randomized controlled trial. Am J Respir Crit Care Med. 2012; 186 (12): 1256-1263.
12. Mekontso-Dessap A, de Prost N, Girou E, et al. B-type natriuretic peptide and weaning from mechanical ventilation. Intensive Care Med. 2006; 32 (10): 1529-1536.
13. Lellouche F, Mancebo J, Jolliet P, et al. A multicenter randomized trial of computer-driven protocolized weaning from mechanical ventilation. Am J Respir Crit Care Med. 2006; 174 (8): 894-900.
14. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999; 18 (6): 695-706.
15. Resche-Rigon M, Azoulay E, Chevret S. Evaluating mortality in intensive care units: contribution of competing risks analyses. Crit Care. 2006; 10 (1): R5.
16. Fine JP, Gray RJ. A proportional hazards model for the model for the subdistribution of a competing risk. J Am Stat Assoc. 1999; 94 (446): 496-509.
17. Gray RJ. A class of K-sample tests for comparing the cumu lative incidence of a competing risk. Ann Stat. 1988; 16 (3): 1141-1154.
18. cmprsk: Subdistribution Analysis of Competing Risks. R Project website. http://cran.r-project.org/web/packages/cmprsk/index.htmlAccessedJuly2012.
19. Martin GS, Mangialardi RJ, Wheeler AP, Dupont WD, Morris JA, Bernard GR. Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Crit Care Med. 2002; 30 (10): 2175-2182.
20. Martin GS, Moss M, Wheeler AP, Mealer M, Morris JA, Bernard GR. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med. 2005; 33 (8): 1681-1687.
21. Mitchell JP, Schuller D, Calandrino FS, Schuster DP. Improved outcome based on fl uid management in critically ill patients requiring pulmonary artery catheterization. Am Rev Respir Dis. 1992; 145 (5): 990-998.
22. National Heart, Lung, and Blood Institute Acute Respira tory Distress Syndrome (ARDS) Clinical Trials Network; Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fl uidmanagement strategies in acute lung injury. N Engl J Med. 2006; 354 (24): 2564-2575.
23. Alberti C, Brun-Buisson C, Chevret S, et al; European Sepsis Study Group. Systemic infl ammatory response and progression to severe sepsis in critically ill infected patients. Am J Respir Crit Care Med. 2005; 171 (5): 461-468.
24. Alberti C, Métivier F, Landais P, Th ervet E, Legendre C, Chevret S. Improving estimates of event incidence over time in populations exposed to other events: application to three large databases. J Clin Epidemiol. 2003; 56 (6): 536-545.
25. Grambauer N, Schumacher M, Dettenkofer M, Beyersmann J. Incidence densities in a competing events analysis. Am J Epidemiol. 2010; 172 (9): 1077-1084.
26. LaForce FM, Mullane JF, Boehme RF, Kelly WJ, Huber GL. The eff ect of pulmonary edema on antibacterial defenses of the lung. J Lab Clin Med. 1973; 82 (4): 634-648.
27. Harris GD, Woods DE, Fine R, Johanson WG Jr. The eff ect of intraalveolar fl uid on lung bacterial clearance. Lung. 1980; 158 (2): 91-100.
28. Jeff eries JM, Cooper T, Yam T, Clarke SC. Pseudomonas aeruginosa outbreaks in the neonatal intensive care unita systematic review of risk factors and environmental sources. J Med Microbiol. 2012; 61 (pt 8): 1052-1061.
29. Brooke JS. S tenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev. 2012; 25 (1): 2-41.
30. Bouadma L, Wolff M, Lucet JC. Ventilator-associated pneumonia and its prevention. Curr Opin Infect Dis. 2012; 25 (4): 395-404.